Abstract
Nanotechnology is a platform long been used as a delivery system for encapsulating therapeutics and/or imaging compounds that are employed for the prevention, diagnosis, and treatment of various diseases. Among the available potential colloidal drug carrier systems, albumin has emerged as a versatile protein used as a carrier system that has been extensively researched for pharmacokinetics and clinical applications. The albumin-based nanoparticles are particularly interesting as attractive macromolecular carriers that are biodegradable and hold great value in the field of nanomedicine due to being well-tolerated without any side effects, having high drug-loading capacity, and with binding efficiency with many drugs, providing a depot and carrier for many small and large molecules alike. Human serum albumin, the most abundant protein present in the human blood, has been used as a carrier in the landmark nanomedicine product, Abraxane (paclitaxel-albumin nanoparticles), establishing its clinical advantage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
